SS Innovations Announces Completion of World鈥檚 First Robotic Telesurgery for Weight Loss with the Company鈥檚 SSi Mantra 3 Surgical Robotic System
SS Innovations (NASDAQ:SSII) has achieved a groundbreaking milestone by completing the world's first robotic telesurgery for weight loss using their SSi Mantra 3 surgical robotic system. The surgery was performed by Dr. Mohit Bhandari from a distance of 560 miles, connecting SS Innovations' headquarters in Gurugram to Mohak Bariatric & Robotic Surgery Centre in Indore, India.
Two One-Anastomosis Gastric Bypass (OAGB) procedures were successfully executed with zero perceptible lag and flawless precision. The achievement demonstrates the system's capability to deliver advanced surgical care to remote locations, potentially revolutionizing healthcare accessibility and affordability globally.
SS Innovations (NASDAQ:SSII) ha raggiunto un traguardo rivoluzionario completando la prima telesurgia robotica al mondo per la perdita di peso utilizzando il loro SSi Mantra 3 sistema robotico chirurgico. L'intervento 猫 stato eseguito dal dott. Mohit Bhandari a una distanza di 560 miglia, collegando la sede di SS Innovations a Gurugram con il Mohak Bariatric & Robotic Surgery Centre a Indore, India.
Due procedure di One-Anastomosis Gastric Bypass (OAGB) sono state eseguite con successo senza alcun ritardo percepibile e con precisione impeccabile. Questo risultato dimostra la capacit脿 del sistema di fornire cure chirurgiche avanzate in luoghi remoti, potenzialmente rivoluzionando l'accessibilit脿 e l'economicit脿 dell'assistenza sanitaria a livello globale.
SS Innovations (NASDAQ:SSII) ha alcanzado un hito innovador al completar la primera telescirug铆a rob贸tica del mundo para la p茅rdida de peso utilizando su sistema quir煤rgico rob贸tico SSi Mantra 3. La cirug铆a fue realizada por el Dr. Mohit Bhandari desde una distancia de 560 millas, conectando la sede de SS Innovations en Gurugram con el Mohak Bariatric & Robotic Surgery Centre en Indore, India.
Se realizaron con 茅xito dos procedimientos de Bypass G谩strico de Una Anastomosis (OAGB) sin retraso perceptible y con una precisi贸n impecable. Este logro demuestra la capacidad del sistema para brindar atenci贸n quir煤rgica avanzada en ubicaciones remotas, lo que podr铆a revolucionar la accesibilidad y asequibilidad de la atenci贸n m茅dica a nivel mundial.
SS Innovations (NASDAQ:SSII)电� SSi Mantra 3 靾橃垹 搿滊磭 鞁滌姢韰�鞚� 鞚挫毄頃橃棳 靹戈硠 斓滌磮搿� 觳挫 臧愲焿鞚� 鞙勴暅 搿滊磭 鞗愱博 靾橃垹鞚� 靹标车鞝侅溂搿� 鞕勲頃樀鐢 須嶊赴鞝侅澑 靹标臣毳� 雼劚頄堨姷雼堧嫟. 靾橃垹鞚� 氇灈 氚橂嫟毽� 氚曥偓臧赌 560毵堨澕 霒柎歆� 瓯半Μ鞐愳劀 靾橅枆頄堨溂氅�, SS Innovations鞚� 甑（攴鸽瀸 氤胳偓鞕� 鞚鸽弰 鞚鸽弰毳挫潣 Mohak 牍勲 氚� 搿滊磭 靾橃垹 靹柬劙毳� 鞐瓣舶頄堨姷雼堧嫟.
霊� 瓯挫潣 雼澕 氍疙暕 鞙勳毎須岇垹 (OAGB)鞚� 歆�鞐� 鞐嗢澊 鞕勲步頃� 鞝曤皜霃勲 靹标车鞝侅溂搿� 靾橅枆霅橃棃鞀惦媹雼�. 鞚措矆 靹标臣电� 觳嫧 靾橃垹 旃橂毳� 鞗愱博歆�鞐愳劀霃� 鞝滉车頃� 靾� 鞛埖鐢 鞁滌姢韰滌潣 電ル牓鞚� 鞛呾頃橂┌, 鞝� 靹戈硠鞝侅溂搿� 鞚橂 鞝戧芳靹标臣 瓴届牅靹膘潉 順侅嫚頃� 鞛犾灛霠レ潉 氤挫棳欷嶋媹雼�.
SS Innovations (NASDAQ:SSII) a franchi une 茅tape majeure en r茅alisant la premi猫re t茅l茅chirurgie robotis茅e au monde pour la perte de poids gr芒ce 脿 leur syst猫me robotique chirurgical SSi Mantra 3. L鈥檌ntervention a 茅t茅 effectu茅e par le Dr Mohit Bhandari 脿 une distance de 560 miles, reliant le si猫ge de SS Innovations 脿 Gurugram au Mohak Bariatric & Robotic Surgery Centre 脿 Indore, en Inde.
Deux proc茅dures de Bypass gastrique 脿 une anastomose (OAGB) ont 茅t茅 r茅alis茅es avec succ猫s, sans aucun d茅calage perceptible et avec une pr茅cision parfaite. Cette r茅ussite d茅montre la capacit茅 du syst猫me 脿 fournir des soins chirurgicaux avanc茅s dans des zones 茅loign茅es, ce qui pourrait r茅volutionner l鈥檃ccessibilit茅 et l鈥檃bordabilit茅 des soins de sant茅 脿 l鈥櫭ヽhelle mondiale.
SS Innovations (NASDAQ:SSII) hat einen bahnbrechenden Meilenstein erreicht, indem es die weltweit erste robotergest眉tzte Teleskopchirurgie zur Gewichtsreduktion mit ihrem SSi Mantra 3 chirurgischen Robotersystem durchgef眉hrt hat. Die Operation wurde von Dr. Mohit Bhandari aus einer Entfernung von 560 Meilen durchgef眉hrt, wobei der Hauptsitz von SS Innovations in Gurugram mit dem Mohak Bariatric & Robotic Surgery Centre in Indore, Indien, verbunden wurde.
Zwei One-Anastomosis Magenbypass (OAGB)-Verfahren wurden erfolgreich mit null wahrnehmbarer Verz枚gerung und makelloser Pr盲zision durchgef眉hrt. Diese Leistung zeigt die F盲higkeit des Systems, fortschrittliche chirurgische Versorgung an entfernte Orte zu bringen und k枚nnte die Zug盲nglichkeit und Erschwinglichkeit der Gesundheitsversorgung weltweit revolutionieren.
- First-ever successful robotic telesurgery for weight loss performed at 560 miles distance
- Zero perceptible lag and flawless precision achieved during the remote procedures
- Technology enables access to specialized surgical care in remote and underserved areas
- System demonstrates potential for reducing healthcare access barriers and patient travel needs
- None.
Insights
SS Innovations achieves groundbreaking robotic telesurgery milestone, demonstrating significant technological capabilities with potential market expansion implications.
This successful demonstration of the SSi Mantra 3 surgical robotic system represents a significant technological achievement in the medical robotics field. Completing a complex bariatric procedure across 560 miles with reportedly zero perceptible lag addresses one of telesurgery's fundamental challenges 鈥� latency issues that typically compromise surgical precision.
The successful execution of One-Anastomosis Gastric Bypass (OAGB) procedures, which require meticulous control and precision, demonstrates the system's advanced capabilities. This particular procedure involves both resection and anastomosis 鈥� technically demanding maneuvers that test the limits of remote robotic control systems.
From a market perspective, this advancement positions SS Innovations to potentially capture market share in both the robotic surgery segment and the emerging telemedicine infrastructure market. The ability to perform complex surgeries remotely has profound implications for healthcare delivery models, particularly in regions with geographic barriers to specialized surgical expertise.
What distinguishes this achievement is the practical demonstration of remote surgical capabilities in a real clinical setting rather than a controlled laboratory environment. While other companies have demonstrated remote surgical capabilities, applying this technology to weight loss surgery 鈥� a high-volume procedure worldwide 鈥� suggests a strategic focus on commercially viable applications rather than merely technological proof-of-concepts.
The technology potentially addresses a critical healthcare disparity by enabling expert surgical care delivery to underserved regions, which may align with both commercial growth opportunities and regulatory favor in developing healthcare markets.
- Led by Dr. Mohit Bhandari, a pioneer in bariatric surgery and President of the Institute of Research Against Digestive Cancer (IRCAD) India, the surgery was remotely performed at a distance of 560 miles and executed on-site at Mohak Bariatric & Robotic Surgery Centre in Indore, India.
- Two advanced One-Anastomosis Gastric Bypass (OAGB) procedures were performed via telesurgery, with zero perceptible lag, flawless precision, and seamless robotic control using the SSI Mantra 3 system.
FORT LAUDERDALE, Fla., July 10, 2025 (GLOBE NEWSWIRE) -- (the 鈥淐ompany鈥� or 鈥淪S Innovations鈥�) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the successful completion of the world鈥檚 first robotic telesurgery for weight loss utilizing the Company鈥檚 advanced SSi Mantra 3 surgical robotic system.
This landmark bariatric telesurgery bridged a distance of 560 miles between SS Innovations' headquarters in Gurugram, India and the Mohak Bariatric & Robotic Surgery Centre in Indore, India. Despite the vast distance, the surgery was performed with zero perceptible lag, flawless precision, and seamless robotic control, setting a new global benchmark for remote surgery capabilities.
The procedures involved two One-Anastomosis Gastric Bypass (OAGB) surgeries, an advanced form of bariatric surgery that reduces stomach size and reroutes the digestive tract to support long-term weight loss and improve metabolic health. The robotic procedures were successfully performed by Dr. Mohit Bhandari, a renowned bariatric surgeon, President of IRCAD India, and Founder & Director of Mohak Bariatric & Robotic Surgery Centre, Indore. Operating from Gurugram, Dr. Bhandari remotely led his Indore-based surgical team, which provided on-site assistance, ensuring expert execution and clinical excellence throughout.
Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, commented, 鈥淲e view this as an additional defining moment for the future of global healthcare. With robotic telesurgery powered by SSi Mantra, we are bridging healthcare gaps and ensuring that world-class surgical expertise reaches even the most remote regions. By successfully performing surgeries across borders, we have shown that distance is no longer a barrier to advanced medical care. We are not just pushing technological boundaries; we are fulfilling our mission to democratize robotic surgery. Telesurgery is revolutionizing healthcare by eliminating the need for patients to travel, making advanced surgical care truly accessible and affordable.鈥�
Dr. Bhandari added, 鈥淲ith the SSi Mantra 3, we have not only demonstrated the immense potential of robotic telesurgery but also redefined the boundaries of surgical care. Performing the world鈥檚 first robotic telesurgery for weight loss is a moment of immense professional pride. This milestone represents a bold new paradigm for access, equity, and excellence in healthcare.鈥�
SS Innovations is leading the charge in revolutionizing surgical care through cutting-edge technology and a strong humanitarian vision, with robotic telesurgeries utilizing SSi Mantra now taking place across hundreds of miles, including in remote and underserved areas. As the Company continues to refine its technology, the focus remains on practical solutions that enhance surgical efficiency, democratize access to specialized care, and improve patient outcomes across India and beyond.
About SS Innovations
SS Innovations International, Inc. (Nasdaq: SSII) develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The Company鈥檚 product range includes its proprietary 鈥淪Si Mantra鈥� surgical robotic system and its comprehensive suite of 鈥淪Si Mudra鈥� surgical instruments, which support a variety of surgical procedures including robotic cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. Visit the Company鈥檚 website at or for more information and updates.
About the SSi Mantra
The SSi Mantra surgical robotic system is a user-friendly, modular, multi-arm system with many advanced technology features, including: 3 to 5 modular robotic arms, an open-faced ergonomic surgeon command center, a large 3D 4K monitor, a touch panel monitor for all patient related information display, a virtual real-time image of the robotic patient side arm carts, and the ability for superimposition of 3D models of diagnostic imaging. A vision cart provides the table-side team with the same magnified 3D 4K view as the surgeon to provide better safety and efficiency. The SSi Mantra utilizes over 40 different types of robotic endo-surgical instruments to support different specialties, including cardiac surgery. The SSi Mantra has been clinically validated in India in more than 100 different types of surgical procedures.
Forward-Looking Statements
This press release may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. The words 鈥渁nticipate,鈥� 鈥渁ssume,鈥� 鈥渂elieve,鈥� 鈥渆stimate,鈥� 鈥渆xpect,鈥� 鈥渨ill,鈥� 鈥渋ntend,鈥� 鈥渕ay,鈥� 鈥減lan,鈥� 鈥減roject,鈥� 鈥渟hould,鈥� 鈥渃ould,鈥� 鈥渟eek,鈥� 鈥渄esigned,鈥� 鈥減otential,鈥� 鈥渇orecast,鈥� 鈥渢arget,鈥� 鈥渙bjective,鈥� 鈥済oal,鈥� or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future events or SS Innovations鈥� future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.
Investor Contact:
The Equity Group聽聽聽聽聽聽聽聽
Kalle Ahl, CFA聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽
T: (303) 953-9878聽聽聽聽聽聽聽聽
Devin Sullivan, Managing Director
T: (212) 836-9608
Media Contact:
RooneyPartners LLC
Kate Barrette
T: (212) 223-0561
FAQ
What breakthrough did SS Innovations (SSII) achieve in robotic surgery?
Who performed the groundbreaking robotic telesurgery for SS Innovations?
What type of weight loss procedures were performed using the SSi Mantra 3 system?
How does SS Innovations' telesurgery technology impact healthcare accessibility?
What was the distance covered in SS Innovations' robotic telesurgery?
